Department of Cardiology, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey.
Department of Cardiology, Hacettepe University Faculty of Medicine, 06100 Ankara, Turkey
Europace. 2015 Feb;17(2):239-46. doi: 10.1093/europace/euu228. Epub 2014 Sep 19.
Atrial fibrosis has been found to be associated with recurrent atrial fibrillation (AF) following catheter ablation. Autoantibodies against M2-muscarinic receptors (anti-M2-R) may play a role in the development of AF by inducing left atrial (LA) fibrosis. In this study, we aim to compare anti-M2-R levels between paroxysmal lone AF patients and healthy control subjects and to investigate the relationship between pre-ablation anti-M2-R level, LA fibrosis quantified by delayed enhancement magnetic resonance imaging (DE-MRI), and AF recurrence following cryoablation.
Thirty-one patients with paroxysmal lone AF (53.4 ± 8.0 years, 61% male), who underwent cryoballoon-based ablation, along with 31 healthy control subjects were included. Enzyme-linked immunosorbent assay tests to measure serum anti-M2-R levels were performed in both groups and DE-MRI was done to quantify LA fibrosis prior to the ablation in the patients. Anti-M2-R levels were higher in the study population when compared with control subjects [212.4 (103.2-655.5) vs. 73.0 (39.5-299.1) ng/mL, P < 0.001]. Anti-M2-R level predicted moderate-extensive LA fibrosis independent of other measures [odds ratio: 1.26 (95% confidence interval (CI): 1.04-1.53), P = 0.017]. At a mean follow-up of 35.2 ± 3.5 months, nine patients (29.0%) had AF recurrence. In the Cox regression model including pre-ablation anti-M2-R level, LA diameter, LA volume index, and moderate-extensive LA fibrosis, only moderate-extensive LA fibrosis predicted late AF recurrence independent of other measures [hazard ratio: 29.41 (95% CI: 3.52-250.00), P = 0.002].
Serum anti-M2-R levels may be associated with the severity of LA fibrosis and may be implicated in the pathophysiology of AF recurrence following cryoablation. Detection of anti-M2-R levels may help select appropriate patients for the procedure.
已经发现,心房纤维化与导管消融后的复发性心房颤动(AF)有关。M2 毒蕈碱受体(anti-M2-R)自身抗体可能通过诱导左心房(LA)纤维化在 AF 的发展中发挥作用。在这项研究中,我们旨在比较阵发性孤立性 AF 患者和健康对照组之间的 anti-M2-R 水平,并研究消融前 anti-M2-R 水平、通过延迟增强磁共振成像(DE-MRI)量化的 LA 纤维化与 cryoablation 后 AF 复发之间的关系。
纳入 31 例接受 cryoballoon 消融的阵发性孤立性 AF 患者(53.4±8.0 岁,61%为男性)和 31 名健康对照组。对两组均进行酶联免疫吸附试验以测量血清 anti-M2-R 水平,并对患者消融前进行 DE-MRI 以量化 LA 纤维化。与对照组相比,研究人群的 anti-M2-R 水平更高[212.4(103.2-655.5)vs. 73.0(39.5-299.1)ng/mL,P<0.001]。anti-M2-R 水平独立于其他措施预测中度至广泛的 LA 纤维化[优势比:1.26(95%置信区间(CI):1.04-1.53),P=0.017]。在平均 35.2±3.5 个月的随访中,9 例患者(29.0%)发生 AF 复发。在 Cox 回归模型中纳入消融前的 anti-M2-R 水平、LA 直径、LA 容积指数和中度至广泛的 LA 纤维化,仅中度至广泛的 LA 纤维化独立于其他措施预测晚期 AF 复发[风险比:29.41(95%CI:3.52-250.00),P=0.002]。
血清 anti-M2-R 水平可能与 LA 纤维化的严重程度有关,并可能与 cryoablation 后 AF 复发的病理生理学有关。检测 anti-M2-R 水平可能有助于为该程序选择合适的患者。